Retatrutide depletes electrolytes through multiple mechanisms
Just check the sugar content first to avoid any blood sugar spikes
Gastrointestinal adverse events - predominantly nausea, vomiting, diarrhea, and constipation - are the most common class effects, occurring in 20%-60% of patients depending on the agent and dose, and are typically of mild-to-moderate severity, dose-dependent, and most prominent during titration
Erica Nelson, MSPH, NBC-HWC Here, at Carolina Total Wellness, we often recommend dietary adjustments to treat a wide variety of symptoms
Abstract Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 receptor agonist)